References
- Kolloch R, Legler UF, Champion A, Cooper-Dehoff RM, Handberg E, Zhou Q, Pepine CJ. Impact of resting heart rate on outcomes in hypertensive patients with coronary artery disease: findings from the International Verapamil-SR/trandolapril Study (INVEST). Eur Heart J. 2008;29(10):1327-1334. PubMed | Google Scholar
- Fox K, Ford I, Steg PG, Tendera M, Robertson M,
Ferrari R, BEAUTIFUL investigators. Heart rate as a
prognostic risk factor in patients with coronary artery disease and left-ventricular
systolic
dysfunction (BEAUTIFUL): a subgroup analysis of a randomised
controlled trial. Lancet. 2008;372(9641):817-821. PubMed | Google
Scholar
- Bertomeu V, Morillas P, Gonzalez-Juanatey JR, Quiles
J, Guindo J, Soria F, Llacer A, Lekuona I, Mazón P, Martín-Luengo C,
Rodriguez-Padial L. Prevalence of Peripheral Arterial
Disease in Patients with Acute Coronary Síndrome (PAMISCA) Investigators
- Prevalence and prognostic influence of peripheral
arterial disease in patients >or=40
years old admitted into hospital following an acute
coronary event. Eur J Vasc Endovasc Surg. 2008;36(2):189-196. Google
Scholar
- Kannel WB, Kannel C, Paffenbarger RS Jr, Cupples LA. Heart rate and cardiovascular mortality. The Framingham Study. Am Heart J. 1987;113(6):1489-1494. PubMed | Google Scholar
- Cooney MT, Vartiainen E, Laatikainen T, Juolevi A, Dudina A, Graham IM. Elevated resting heart rate is an independent risk factor for cardiovascular disease in healthy men and women. Am Heart J. 2010;159(4):612-619. PubMed | Google Scholar
- Jouven X, Desnos M, Guerot C, Ducimetičre P. Predicting sudden death in the population: The Paris Prospective Study I. Circulation. 1999;99(15):1978-1983. PubMed | Google Scholar
- Mensink GB, Hoffmeister H. The relationship between resting heart rate and all-cause, cardiovascular and cancer mortality. Eur Heart J. 1997;18(9):1404-1410. PubMed | Google Scholar
- Han Z, Yan-min Y, Jun Z, Li-sheng L, Hui-qiong T, Yao L. Prognostic value of admission heart rate in patients with ST-segment elevation myocardial infarction: role of type 2 diabetes mellitus. BMC Cardiovasc Disord. 2012;12:104. PubMed | Google Scholar
- Honda T, Kanazawa H, Koga H, Miyao Y, Fujimoto K. Heart rate on admission is an independent risk factor for poor cardiac function and in-hospital death after acute myocardial infarction. J Cardiol. 2010;56(2):197-203. PubMed | Google Scholar
- Davidovic G, Iric-Cupic V, Milanov S. Associated influence of hypertension and heart rate greater than 80 beats per minute on mortality rate in patients with anterior wall STEMI. Int J Clin Exp Med. 2013;6(5):358-366. PubMed | Google Scholar
- Davidovic G, Iric-Cupic V, Milanov S, Dimitijevic A, Petrovic-Janicijevic M. When heart goes "BOOM" to fast - Heart rate greater than 80 as mortality predictor in acute myocardial infarction. Am J Cardiovasc Dis. 2013;3(3):120-128. PubMed | Google Scholar
- Bangalore S, Messerli FH, Ou FS, Tamis-Holland J, Palazzo A, Roe MT, Hong MK, Peterson ED, CRUSADE Investigators. The association of admission heart rate and in-hospital cardiovascular events in patients with non-ST-segment elevation acute coronary syndromes: results from 135 164 patients in the CRUSADE quality improvement initiative. Eur Heart J. 2010;31(5):552-560. PubMed | Google Scholar
- Asaad N, El-Menyar A, AlHabib KF, Shabana A, Alsheikh-Ali AA, Almahmeed W, Al Faleh H, Hersi A, Al Saif S, Al-Motarreb A, Sulaiman K, Al Nemer K, Amin H, Al Suwaidi J. Initial heart rate and cardiovascular outcomes in patients presenting with acute coronary syndrome. Acute Card Care. 2014;16(2):49-56. PubMed | Google Scholar
- Timóteo AT, Toste A, Ramos R, Oliveira JA, Ferreira ML, Ferreira RC. Admission heart rate as a predictor of mortality in patients with acute coronary syndromes. Acute Card Care. 2011;13(4):205-210. PubMed | Google Scholar
- Kovar D, Cannon CP, Bentley JH, Charlesworth A, Rogers WJ. Does initial and delayed heart rate predict mortality in patients with acute coronary syndromes?. Clin Cardiol. 2004;27(2):80-86. PubMed | Google Scholar
- Fácila L, Morillas P, Quiles J, Soria F, Cordero
A, Mazón P, Anguita M, Martín-Luengo C, Gonzalez-Juanatey JR, Bertomeu
V. The prevalence of peripheral arterial disease in
patients with acute coronary syndrome (PAMISCA) - Prognostic
significance of heart rate in
hospitalized patients presenting with myocardial infarction.
World J Cardiol. 2012;4(1):15-19. Google
Scholar
- Alpert JS, Thygesen K, Antman E, Bassand JP. Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol. 2000;36(3):959-969. PubMed | Google Scholar
- Braunwald E. Unstable angina - A classification. Circulation. 1989;80(2): 410-414. PubMed | Google Scholar
- Lip GY, Windecker S, Huber K, Kirchhof P, Marin F, Ten Berg JM, Haeusler KG, Boriani G, Capodanno D, Gilard M, Zeymer U, Lane D, Document Reviewers, Storey RF, Bueno H, Collet JP, Fauchier L, Halvorsen S, Lettino M, Morais J, Mueller C, Potpara TS, Rasmussen LH, Rubboli A, Tamargo J, Valgimigli M, Zamorano JL. Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary or valve interventions: a joint consensus document of the European Society of Cardiology Working Group on Thrombosis, European Heart Rhythm Association (EHRA), European Association of Percutaneous Cardiovascular Interventions (EAPCI) and European Association of Acute Cardiac Care (ACCA) endorsed by the Heart Rhythm Society (HRS) and Asia-Pacific Heart Rhythm Society (APHRS). Eur Heart J. 2014;35(45):3155-3179. PubMed | Google Scholar
- Bryniarski L, Pelc-Nowicka A, Zabojszcz M, Mirek-Bryniarska
E. Dual antiplatelet therapy and antithrombotic treatment: recommendations
and controversies. Cardiol J. 2009;16(2):179-189 Review. PubMed | Google
Scholar
- Mehta RH, Dabbous OH, Granger CB, Kuznetsova P, Kline-Rogers EM, Anderson FA Jr, Fox KA, Gore JM, Goldberg RJ, Eagle KA, GRACE Investigators. Comparison of outcomes of patients with acute coronary syndromes with and without atrial fibrillation. Am J Cardiol. 2003;92(9):1031-1036. PubMed | Google Scholar
- Roy D, Talajic M, Dorian P, Connolly S, Eisenberg MJ, Green M, Kus T, Lambert J, Dubuc M, Gagné P, Nattel S, Thibault B. Amiodarone to prevent recurrence of atrial fibrillation. Canadian Trial of Atrial Fibrillation Investigators. N Engl J Med. 2000;342(13):913-920. PubMed | Google Scholar
- Ahmed S, Rienstra M, Crijns HJ, Links TP, Wiesfeld AC, Hillege HL, Bosker HA, Lok DJ, Van Veldhuisen DJ, Van Gelder IC, CONVERT Investigators. Continuous vs episodic prophylactic treatment with amiodarone for the prevention of atrial fibrillation: a randomized trial. JAMA. 2008 ;300(15):1784-1792. PubMed | Google Scholar
- Sairaku A, Nakano Y, Oda N, Makita Y, Kajihara K, Tokuyama T, Motoda C, Fujiwara M, Kihara Y. How many electrical cardioversions should be applied for repetitive recurrences of atrial arrhythmias following ablation of persistent atrial fibrillation?. Europace. 2011;13(12):1703-1708. PubMed | Google Scholar
- Kotecha D, Holmes J, Krum H, Altman DG, Manzano
L, Cleland JG, Lip GY, Coats AJ, Andersson B, Kirchhof
P, von Lueder TG, Wedel H, Rosano G, Shibata MC, Rigby
A, Flather MD, Beta-Blockers
in Heart Failure Collaborative Group. Efficacy of ß blockers
in patients with heart failure plus atrial fibrillation:
an individual-patient data meta-analysis. Lancet. 2014;384(9961):2235-2243. Google
Scholar
- Caldentey G, Khairy P, Roy D, Leduc H, Talajic M, Racine N, White M, O'Meara E, Guertin MC, Rouleau JL, Ducharme A. Prognostic value of the physical examination in patients with heart failure and atrial fibrillation: insights from the AF-CHF trial (atrial fibrillation and chronic heart failure). JACC Heart Fail. 2014;2(1):15-23. PubMed | Google Scholar
- Heist EK, Mansour M, Ruskin JN. Rate control in atrial fibrillation: targets, methods, resynchronization considerations. Circulation. 2011;124(24):2746-2755. PubMed | Google Scholar
- Benetos A, Rudnichi A, Thomas F, Safar M, Guize L. Influence of heart rate on mortality in a French population: role of age, gender and blood pressure. Hypertension. 1999;33(1):44-52. PubMed | Google Scholar
- Boersma E, Pieper KS, Steyerberg EW, Wilcox RG, Chang WC, Lee KL, Akkerhuis KM, Harrington RA, Deckers JW, Armstrong PW, Lincoff AM, Califf RM, Topol EJ, Simoons ML. Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation - Results from an international trial of 9461 patients - The PURSUIT Investigators. Circulation. 2000;101(22):2557-2567. PubMed | Google Scholar
- Granger CB, Goldberg RJ, Dabbous O, Pieper KS, Eagle KA, Cannon CP, Van De Werf F, Avezum A, Goodman SG, Flather MD, Fox KA, Global Registry of Acute Coronary Events Investigators. Predictors of hospital mortality in the global registry of acute coronary events. Arch Intern Med. 2003;163(19):2345-2353. PubMed | Google Scholar
- Lechat P, Hulot JS, Escolano S, Mallet A, Leizorovicz A, Werhlen-Grandjean M, Pochmalicki G, Dargie H. Heart rate and cardiac rhythm relationships with bisoprolol benefit in chronic heart failure in CIBIS II Trial. Circulation. 2001;103(10):1428-1433. PubMed | Google Scholar
- Castagno D, Skali H, Takeuchi M, Swedberg K, Yusuf S, Granger CB, Michelson EL, Pfeffer MA, McMurray JJ, Solomon SD; CHARM Investigators. Association of heart rate and outcomes in a broad spectrum of patients with chronic heart failure: results from the CHARM (Candesartan in Heart Failure: Assessment of Reduction in Mortality and morbidity) program. J Am Coll Cardiol. 2012;59(20):1785-1795. PubMed | Google Scholar